XML 68 R57.htm IDEA: XBRL DOCUMENT v3.5.0.2
RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities      
Net income (loss) $ (10,362,335) $ (25,033,872) $ 2,003,326
Net income (loss) from discontinued operations (3,500,112) (25,956,512) 2,900,748
Net income from continuing operations 6,862,223 (922,640) 897,422
Adjustments to reconcile net income to net cash (used in) provided by operating activities      
Stock-based compensation expense 1,055,744 1,408,421 239,871
Depreciation and amortization 619,207 269,595 216,369
Change in fair value of warrants liability (390,324) (2,866,171) 346,691
Change in deferred tax assets 0 125,676 (2,698)
Provision for accounts receivable 10,014 35,900 0
Provision for other receivables (1,899) 27,200 0
Provision for advances to suppliers - third parties 429 326,098 0
Change in warranty reserve (120,105) (209,227) 0
Provision for inventory obsolescence 16,203 142,207 0
Changes in assets and liabilities:      
(Increase) Decrease in accounts receivable (487,197) 1,743,792 2,366,023
Decrease in advances to suppliers - third parties 1,005,042 3,751,434
Increase in advance to supplier - related party 623,583 (1,498,627) (4,004,830)
Increase in other receivables 1,605,521 (443,285) 2,265,617
Increase in inventories 92,020 (3,676,810) (171,634)
Decrease in taxes receivable 0 372,935 (34,569)
Increase in long-term prepaid expenses (166,548) (142,377)  
Decrease in accounts payable 208,457 (19,710) 72,791
Decrease in advances from customers (18,463) (256,504) 278,300
Decrease in accrued expenses and other current liabilities 1,337,741 (33,961) 85,926
Increase in taxes payable (20,702) 52,064 (325,464)
Net cash (used in) provided by operating activities from continuing operations (1,493,500) 31,290 434,971
Net cash provided by operating activities from discontinued operations (851,315) 4,106,063 (635,421)
Net cash provided by (used in) operating activities (2,344,815) 4,137,353 (200,450)
Cash flows from investing activities      
Capital expenditures and other additions (27,861) (2,053,039) (8,536)
Purchases of intangible assets 0 (3,353,353) 0
Net cash used in investing activities from continuing operations (27,861) (5,406,392) (8,536)
Net cash used in investing activities from discontinued operations 0 (5,791,256) (1,122,085)
Net cash used in investing activities (27,861) (11,197,648) (1,130,621)
Cash flows from financing activities      
Proceeds from bank loan 4,008,975 2,944,000 2,503,747
Repayments of bank loan (4,810,770) (2,948,700) (2,502,457)
Net proceeds from option exercises 36,250 194,300 0
Net proceeds from issuance of common stock 0 6,066,546 0
Net cash provided by financing activities 1,498,724 6,256,146 330,866
Effect of exchange rate fluctuations on cash and cash equivalents (229,087) (61,033) 87,820
Net decrease in cash and cash equivalents (1,103,039) (865,182) (912,385)
Cash and cash equivalents at beginning of year 1,727,763 2,592,945 3,505,330
Cash and cash equivalents at end of year 624,724 1,727,763 2,592,945
Supplemental Cash Flow Information [Abstract]      
Income tax paid 0 188,695 688,219
Interest paid 196,220 176,231 159,482
Scenario, Previously Reported [Member]      
Cash flows from operating activities      
Net income (loss)   659,004  
Net income (loss) from discontinued operations   (1,088,208)  
Net income from continuing operations   (1,747,212)  
Adjustments to reconcile net income to net cash (used in) provided by operating activities      
Stock-based compensation expense   1,408,421  
Depreciation and amortization   269,595  
Change in fair value of warrants liability   (2,866,171)  
Change in deferred tax assets   (282,041)  
Provision for accounts receivable   8,351  
Provision for other receivables   0  
Provision for advances to suppliers - third parties   0  
Change in warranty reserve   (209,227)  
Provision for inventory obsolescence   106,199  
Changes in assets and liabilities:      
(Increase) Decrease in accounts receivable   1,743,792  
Decrease in advances to suppliers - third parties   3,751,434  
Increase in advance to supplier - related party   (1,498,627)  
Increase in other receivables   (443,285)  
Increase in inventories   (3,676,810)  
Decrease in taxes receivable   372,935  
Increase in long-term prepaid expenses   (142,377)  
Decrease in accounts payable   (19,710)  
Decrease in advances from customers   (256,504)  
Decrease in accrued expenses and other current liabilities   (33,961)  
Increase in taxes payable   52,064  
Net cash (used in) provided by operating activities from continuing operations   31,290  
Net cash provided by operating activities from discontinued operations   4,106,063  
Net cash provided by (used in) operating activities   4,137,353  
Cash flows from investing activities      
Capital expenditures and other additions   (2,053,039)  
Purchases of intangible assets   (3,353,353)  
Net cash used in investing activities from continuing operations   (5,406,392)  
Net cash used in investing activities from discontinued operations   (5,791,256)  
Net cash used in investing activities   (11,197,648)  
Cash flows from financing activities      
Proceeds from bank loan   2,944,000  
Repayments of bank loan   (2,948,700)  
Net proceeds from option exercises   194,300  
Net proceeds from issuance of common stock   6,066,546  
Net cash provided by financing activities   6,256,146  
Effect of exchange rate fluctuations on cash and cash equivalents   (61,033)  
Net decrease in cash and cash equivalents   (865,182)  
Cash and cash equivalents at beginning of year 1,727,763 2,592,945  
Cash and cash equivalents at end of year   1,727,763 2,592,945
Supplemental Cash Flow Information [Abstract]      
Income tax paid   188,695  
Interest paid   176,231  
Restatement Adjustment [Member]      
Cash flows from operating activities      
Net income (loss)   (25,692,876)  
Net income (loss) from discontinued operations   (24,868,304)  
Net income from continuing operations   824,572  
Adjustments to reconcile net income to net cash (used in) provided by operating activities      
Stock-based compensation expense   0  
Change in fair value of warrants liability   0  
Change in deferred tax assets   407,717  
Provision for accounts receivable   27,549  
Provision for other receivables   27,200  
Provision for advances to suppliers - third parties   326,098  
Change in warranty reserve   0  
Provision for inventory obsolescence   36,008  
Changes in assets and liabilities:      
(Increase) Decrease in accounts receivable   0  
Decrease in advances to suppliers - third parties   0  
Increase in advance to supplier - related party   0  
Increase in other receivables   0  
Increase in inventories   0  
Decrease in taxes receivable   0  
Increase in long-term prepaid expenses   0  
Decrease in accounts payable   0  
Decrease in advances from customers   0  
Decrease in accrued expenses and other current liabilities   0  
Increase in taxes payable   0  
Net cash (used in) provided by operating activities from continuing operations   0  
Net cash provided by operating activities from discontinued operations   0  
Net cash provided by (used in) operating activities   0  
Cash flows from investing activities      
Capital expenditures and other additions   0  
Purchases of intangible assets   0  
Net cash used in investing activities from continuing operations   0  
Net cash used in investing activities from discontinued operations   0  
Net cash used in investing activities   0  
Cash flows from financing activities      
Proceeds from bank loan   0  
Repayments of bank loan   0  
Net proceeds from option exercises   0  
Net proceeds from issuance of common stock   0  
Net cash provided by financing activities   0  
Effect of exchange rate fluctuations on cash and cash equivalents   0  
Net decrease in cash and cash equivalents   0  
Cash and cash equivalents at beginning of year $ 0 0  
Cash and cash equivalents at end of year   0 $ 0
Supplemental Cash Flow Information [Abstract]      
Income tax paid   0  
Interest paid   $ 0